Structure-activity relationships in a series of (5i?)-6-triazolylmethylene penems with potent /Mactamase inhibitory activity are described. In most cases, their in vitro synergistic activity with amoxycillin is superior to that of clavulanic acid, sulbactam and tazobactam (YTR830). Against an Escherichia coli TEM-1infection in mice, the compoundsshowed a broad range of potencies; an optimum polarity was found, however, which gave maximumpotency.
Reagents:
(i) Ph2NLi, THF, -70°C; (ii) 9; (iii) Ac2O; (iv) Zn, NH4C1, (CH3)2NCH2CH2N(CH3)2-2HC1, DMF; (v) A1C13, anisole, CH2C12, -40°C; (vi) aq Na2HPO4.
ester (8) and either of the chiral azetidinones (1 or 2). Route B (Scheme 2) has also been described for .
R R the preparation of 5b6~9); it requires a 1,2,3-triazolecarboxaldehyde (9) and the (6S)-bromoa H n CH2COOPNB y W K J bCH3 pCH2COONa
penem (6)9). e DMT q N(CH3)2
The triazole esters (8b~8e) were prepared by f Et r OCH3 by comparison with an authentic sample3'; 8c and j CHcqocH Ph w (CH ) OH 8d were progressed by route A to penems (4c and m CH2COOSiPh2Bu' x (CH2)3OSi(CH3)2Buf 4d) and the structures identified by NOEstudies. In This table refers to compounds 3, 4, 5, 7, 8 and 9 (a, 4d , a strong NOEbetween lO-TV-methyl and 8-CH b and e^x)-For c and d' see seParate structures. The DMTgroup in e is written in the N-12 position for was observed, but in 4c no NOEto ll-TV-methyl convenience, although its position is unknown. VOL.44 NO.9 THE JOURNAL OF ANTIBIOTICS could be seen (for numbering, see structure 4c). Triazole esters (8f, 8g, 8j~81, 8q~8s, 8u and 8w) were prepared by an extension of the method of Stojanovic and Arnold10), by which ethyl a-formyldiazoacetate was condensed with amines, 1,1-dimethyl hydrazine and oxyamines. Hydroxy derivatives (8s, 8u and 8w) required protection as 8t, 8v and 8x. Triazole (81) reacted with the anion from 1 mainly at the benzyl ester; it was therefore converted into 8m. Triazole aldehydes (9t, 9v and 9x) were obtained from 8t, 8v and 8x by a standard reduction-oxidation sequence. Penem esters (4e, and 7v and 7x) required deprotection to 4a, and 7u and 7w before de-esterification. In the cases of 4n and 7t the de-esterification conditions served to remove both protecting groups. De-esterification of 4g also resulted in alkyl group hydrogenation to give 5h.
Biology Table 2 shows the effects on biological activity of altering the position of the methyl group on the triazole ring. An N-101 methyl substituent (5d) resulted in a marked loss of synergistic activity with amoxycillin, as expected from the previously established structure-activity relationships in the 5-membered heterocyclic series3), and also resulted in poor in vivo activity relative to the iV-12-methylated derivative (5b). The N-\ 1 -methylated derivative (5c) showed reduced synergistic activity against the Class 1 /Mactamase of Enterobacter aerogenes, but synergistic activity against all other /Mactamases was similar to that seen with 5b. The good in vitro activity of 5c against the TEM-1enzymewas not evident in vivo, however.
Thus, the 7V-12-methyl derivative (5b) was clearly the most active of the three, and a number of compounds were synthesised which contained other small alkyl groups at the N-12 position (Table 3) . There was very little difference in the synergistic activity with amoxycillin shown by these compounds, and all twelve proved better broad spectrum synergists than clavulanic acid, sulbactam or tazobactam (YTR 830) . This increased potency was most noticeable against organisms producing the Class 1 or OXA-1 enzyme. All derivatives, except perhaps the parent (5a), were reasonably stable to human kidney homogenate, and none showed excessively high binding to human serum. Whentested in vivo against an Escherichia coli TEM-1infection in mice, however, these compoundsrevealed a very broad range of For numbering, see structure 4c. Table 3 . Biological activity of N-12-substituted triazolylmethylene penems. SEPT. 1991 Amoxycillin MIC (/ig/ml) in the presence of 1 jug/ml of inhibitor Abbreviations: See footnote in Table 2. potencies with only 7 out of 12 showing a greater potency than clavulanic acid, and only one compound (5u) showing potency equal to that of 5b. The logk' parameter11} can be used as a measure of the polarity of these derivatives, and a plot of log k' against log relative potency gave a curve ( The Ar-n-methyltriazolyl derivative (5b) is one of two compoundsfalling within the area of maximal potency on the curve, and the biological activity of this derivative is described in more detail in a separate publication13 MICswere determined in microtitre plates by serial dilution of amoxycillin in broth, followed by addition of inhibitor (1 jug/mi) and organism (approx 2 x 106 cfu/ml) as previously described140.
Serum binding was carried out using the method previously described40.
Stability to human kidney homogenate was determined at 37°C as described previously40. Since compounds were chiral, treatment with Bacillus cereus II enzymewas not necessary. The 50% curative dose (CD50) determinations were performed in mice. The organism (E. coli E96) was suspended in 3%hog gastric mucin +1%carboxymethylcellulose at 100xLD50, and 0.5ml of suspension was injected ip into groups of five mice. Compoundswere administered subcutaneously at 2mg/kg with varying doses of amoxycillin at 1 and 5 hours post-infection. Survivors were recorded over a 4-day period. The CD50of amoxycillin in the presence of inhibitor was calculated using log probit analysis. Compound 5b was used as control in every experiment, and the data were normalised by conversion to relative potencies thus:
CD50 of compound 5b/CD5O of test compound. Logk' was calculated from the reverse phase HPLCRt's using the method of Miyake et al}l\ All compounds were chromatographically pure as shown by TLCon Merck Silica gel 60 F254 plates. Chromatography of intermediates was carried out using Merck Silica gel 60, eluting with EtOAc -hexane mixtures, and of sodium salts using either Bio-Gel P-2 (route A) or Diaion HP-20SS (route B). HPLC was carried out using Beckmanequipment with an Ultrasphere ODScolumn, eluting with MeOH-pH 7.4 phosphate buffer. Instrumentation for IR, NMR,UVand mass spectra and mp's is as described in previous papers of this series1~4). Optical rotations of all chiral compoundswere measured on a PerkinElmer 141 polarimeter. All new compounds gave satisfactory IR, NMR,MSand/or microanalysis, and
UVwhere applicable.
Azetidinone (1) ([a]£°-55°C (c 1, CHC13)) was prepared from (4i?)-4-tritylthioazetidinone15) using a silylation procedure described for the corresponding racemic compound16*. Bromoazetidinone (2) has been described5). Triazole (8a) was prepared by the method of Klein et al.17) . Full experimental details are in the patent literature for both routes A5) and B9). A minor modification to route A was that KF-MeOH treatment of 3m caused double desilylation, but re-esterification with NaH-PNBbromide and continuation of the synthesis produced (4n). In route B some (jE)-isomer was produced along with 7; this was removed either chromatographically or by crystallisation oi 7. Geometries were assigned as already described7).
Ethyl W-Methyl-1 ,2,3-triazole Carboxylates (8b~8d) Triazole (8a) (10 g, 71 mmol) in DMF(120ml) was ice-cooled and treated with K2CO3 (6 g, 43.5 mmol) and Mel (4.67ml, 75 mmol). After stirring 24 hours at room temperature, the DMFwas evaporated and the residue taken up in EtOAc-water. The EtOAcwas further washed with Na2S2O3soln and water, dried (MgSO4) and evaporated. Chromatography separated the three isomeric TV-methyl compounds: 8b (1.99g, 18%, Rf0.15 in EtOAc-hexane, 2:3), 8c (4g, 36%, Rf0.76) and 8d (3.2g, 29%, Rf0.66) were identified as described in the chemistry section. Protection of Triazoles (8s, 8u and 8w) Ethyl l -/7-Methoxybenzyloxy-l ,2,3-triazole-4-carboxylate (8t) Triazole (8s) (6 g, 38.2 mmol) in DMF(40 ml) was treated with diazabicycloundecene (DBU) (7.45 ml, 50mmol) and a solution of />-methoxybenzyl (PMB) bromide (prepared from PBr3 and PMBalcohol 50mmol and used crude) in DMF(10ml Anal CalcdforC14H27N3O3Si: C 53. 7, H 8.6, N 13.4. Found: C 53.8, H 8.8, N 13.5. Ethyl l -(rgrr-Butyldiphenylsilyloxycarbonylmethyl)-l ,2,3-triazole-4-carboxylate (8m) Benzyl ester (81) (10g, 34.6mmol) in THF (200ml) with 10% Pd-C (1 g) was shaken under H2 at atmospheric pressure until H2 uptake stopped (15 minutes). The catalyst was filtered off and the filtrate ice-cooled, treated with Et3N (5.3 ml, 38 mmol) and ter/-butyldiphenylsilyl chloride (10 ml, 38 mmol) and left 20 minutes. The solvent was evaporated, the residue taken up in EtOAcand filtered. The filtrate was evaporated to about 80ml and left to crystallise to provide colourless needles (13. Anal CalcdforCnHiaNaOa: C 56. 2, H 5.5, N 17.9. Found: . C 55. 9, H 5.7, N 17.6 . Oxidation of Alcohol: The above triazolemethanol (1.3 g, 5.5mmol ) in CH2C12 (25ml) was stirred vigorously with pyridinium dichromate (9g) for 3 hours, diluted with EtOAc (300 ml) and filtered through Celite. Evaporation of the filtrate and chromatography gave 9t (0.59g, 46%), which crystallised (EtOAc -hexane) as colourless plates: Melting range 87~95°C.
IR H 4.7, N 18.0. Found: C 56.6, H 4.3, N 18.0. DMTRemoval from Penem (4e) Penem (4e) (0.57 g, 0.83 mmol) in CH2C12(2O ml) and PrOH (20 ml) was ice-cooled and treated dropwise over 10 minutes with formic acid (25ml). CH2C12(30ml) and water (100ml) were added, followed by solid NaHCO3 until basic. The organic layer was separated, dried and evaporated. Chromatography and crystallisation (EtOAc -hexane) provided (4a) Desilylation of Penem (7v) Penem (7v) (18.4 g, 35 mmol) in THF (1 10 ml) and AcOH(90 ml) was treated with tetrabutylammonium fluoride in THF(70ml, 1 m) and stirred 3 hours. The soln was diluted with EtOAc, washed with water and aqueous NaHCO3,dried and evaporated. The solid was briefly (2 minutes) boiled with EtOAc -CHC13 (1 : 1) (100ml), left 2 minutes and the crystals filtered off to provide pure (5R\ (6Z) penem (7u), (5 Irradiation of N-CH3 produced an NOEto 8-CH; irradiation of 5-CH produced an NOEto 13-CH; these NOE's were also seen in the reverse direction. The absence of an NOEto N-CH3in 4c and its presence in 4d verifies these structures. Also,,the fact that in 4c there are NOE's from 13-CH to both 5-CH and 8-CH indicates relatively free rotation of the triazole group; in 4d the absence of an NOEfrom 13-CH to 8-CH and from N-CH3 to 5-CH indicates a relatively fixed triazole position due to steric hindrance by the N-CH3.
Deprotection of Penem Esters (4 and 7) to Sodium Salts (5) SEPT. 1991 RouteA A general deprotection of penem /?-nitrobenzyl (PNB) esters is available2 '5 
